Schedule 13G ownership disclosure
ASTRIA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 04635X102
Event date: 2025-06-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Integrated Core Strategies (US) LLC
Shares: 2,868,294.00 · Class: 5.1%
- Millennium Management LLC
Shares: 2,937,803.00 · Class: 5.2%
- Millennium Group Management LLC
Shares: 2,937,803.00 · Class: 5.2%
- Israel A. Englander
Shares: 2,937,803.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-060630
- Form type
- SCHEDULE 13G
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Jun 18, 2025
- Reporting period
- Jun 13, 2025
- Description
- Schedule 13G beneficial ownership